197 related articles for article (PubMed ID: 12679730)
1. Update on the current use of hormonals as therapy in advanced breast cancer.
Vogel CL
Anticancer Drugs; 2003 Apr; 14(4):265-73. PubMed ID: 12679730
[TBL] [Abstract][Full Text] [Related]
2. Use of aromatase inhibitors in postmenopausal women with advanced breast cancer.
Roseman BJ; Buzdar AU; Singletary SE
J Surg Oncol; 1997 Nov; 66(3):215-20. PubMed ID: 9369969
[TBL] [Abstract][Full Text] [Related]
3. Aromatase inhibitors in early breast cancer treatment.
Mauriac L; Smith I
Semin Oncol; 2003 Aug; 30(4 Suppl 14):46-57. PubMed ID: 14513436
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effects of letrozole.
Miller WR; Anderson TJ; Dixon JM
Cancer Invest; 2002; 20 Suppl 2():15-21. PubMed ID: 12442345
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of aromatase inhibitors in the treatment of breast cancer.
Harvey HA
Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):32-5. PubMed ID: 9556789
[TBL] [Abstract][Full Text] [Related]
6. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
Howell A; Howell SJ; Clarke R; Anderson E
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy of aromatase inhibitors in second-line treatment of metastatic breast cancer.
Rose C
Am J Clin Oncol; 2003 Aug; 26(4):S9-16. PubMed ID: 12902872
[TBL] [Abstract][Full Text] [Related]
8. [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects].
de Cremoux P; Diéras V; Poupon MF; Magdelénat H; Sigal-Zafrani B; Fourquet A; Pierga JY
Bull Cancer; 2004 Dec; 91(12):917-27. PubMed ID: 15634633
[TBL] [Abstract][Full Text] [Related]
9. Antiaromatase agents: evolving role in adjuvant therapy.
Jones SE
Clin Breast Cancer; 2002 Apr; 3(1):33-42. PubMed ID: 12020394
[TBL] [Abstract][Full Text] [Related]
10. Preliminary data from ongoing adjuvant aromatase inhibitor trials.
Goss PE
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4397s-4401s; discussion 4411s-4412s. PubMed ID: 11916231
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
Gibson LJ; Dawson C; Lawrence DH; Bliss JM
Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
[TBL] [Abstract][Full Text] [Related]
12. A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women.
Cardoso F; Bischoff J; Brain E; Zotano ÁG; Lück HJ; Tjan-Heijnen VC; Tanner M; Aapro M
Cancer Treat Rev; 2013 Aug; 39(5):457-65. PubMed ID: 22840697
[TBL] [Abstract][Full Text] [Related]
13. A summary of second-line randomized studies of aromatase inhibitors.
Buzdar AU
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):109-14. PubMed ID: 11850214
[TBL] [Abstract][Full Text] [Related]
14. Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings.
Ingle JN; Suman VJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):313-9. PubMed ID: 14623527
[TBL] [Abstract][Full Text] [Related]
15. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
Friedrichs K; Jänicke F
Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
[TBL] [Abstract][Full Text] [Related]
16. Endocrine therapy in the treatment of metastatic breast cancer.
Buzdar AU
Semin Oncol; 2001 Jun; 28(3):291-304. PubMed ID: 11402439
[TBL] [Abstract][Full Text] [Related]
17. Use of aromatase inhibitors in the adjuvant treatment of breast cancer.
Baum M
Endocr Relat Cancer; 1999 Jun; 6(2):231-4. PubMed ID: 10731114
[TBL] [Abstract][Full Text] [Related]
18. Third generation aromatase inhibitors in metastatic breast cancer patients failing tamoxifen. Randomized comparisons with megestrol acetate: a critical review.
Bonte J
Eur J Gynaecol Oncol; 2000; 21(6):555-9. PubMed ID: 11214609
[No Abstract] [Full Text] [Related]
19. Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors.
Goss PE; Strasser K
Drugs; 2002; 62(6):957-66. PubMed ID: 11929341
[TBL] [Abstract][Full Text] [Related]
20. Role of anti-aromatase agents in postmenopausal advanced breast cancer.
Murray R
Cancer Chemother Pharmacol; 2001 Oct; 48(4):259-65. PubMed ID: 11710624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]